Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity

Prostate-specific membrane antigen (PSMA)-targeted radioligands have been used for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Recently, albumin-binding PSMA radioligands with enhanced blood circulation were developed to increase the tumor accumulation of activity. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Deberle, Luisa M., Benešová, Martina, Umbricht, Christoph A., Borgna, Francesca, Büchler, Manuel, Zhernosekov, Konstantin, Schibli, Roger, Müller, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993238/
https://www.ncbi.nlm.nih.gov/pubmed/32042329
http://dx.doi.org/10.7150/thno.40482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993238/
https://www.ncbi.nlm.nih.gov/pubmed/32042329
http://dx.doi.org/10.7150/thno.40482

Ejemplares similares